Minimal Viable Hospital: How Many Systems Do We Really Need?

The path forward is not about abandoning technology; it is about redefining how healthcare organizations plan for the ...
The American Journal of Managed Care

Overcoming Pain Points to Advance Bispecifics in the Community for Patients With Myeloma

Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...

Rezolute: Phase 3 sunRIZE Data For Ersodetug Warrants Downgrade To Sell Rating

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...
Opinion
STATOpinion

How hepatitis B vaccine changes could add confusion for families, limit protection against other diseases

How a new recommendation on hepatitis B vaccination could add confusion for families and limit protection against other diseases.
Medical Xpress

IV iron improves survival, increases hemoglobin in patients with iron-deficiency anemia and acute infection

Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with iron-deficiency anemia who were hospitalized for an acute bacterial infection, ...
The New Yorker

Oliver Sacks Put Himself Into His Case Studies. What Was the Cost?

When Oliver Sacks arrived in New York City, in September, 1965, he wore a butter-colored suit that reminded him of the sun. He had just spent a romantic week in Europe travelling with a man named Jenö ...
Managed Healthcare Executive

Efficacy and Safety of Intravenous Induction and Subcutaneous Maintenance Therapy with Guselkumab for Patients with Crohn’s Disease: Written Recap

Guselkumab showed superior efficacy over placebo and ustekinumab in achieving clinical and endoscopic remission in Crohn's disease. The GALAXI trials' design, including treat-through methodology and ...